DK4005555T3 - Fremgangsmåder til at sikre resuspension af paliperidonpalmitat-formuleringer - Google Patents
Fremgangsmåder til at sikre resuspension af paliperidonpalmitat-formuleringer Download PDFInfo
- Publication number
- DK4005555T3 DK4005555T3 DK21210307.1T DK21210307T DK4005555T3 DK 4005555 T3 DK4005555 T3 DK 4005555T3 DK 21210307 T DK21210307 T DK 21210307T DK 4005555 T3 DK4005555 T3 DK 4005555T3
- Authority
- DK
- Denmark
- Prior art keywords
- resuspension
- ensuring
- methods
- paliperidone palmitate
- formulations
- Prior art date
Links
- VOMKSBFLAZZBOW-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl hexadecanoate Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC3=C(C)N=C4N(C3=O)CCCC4OC(=O)CCCCCCCCCCCCCCC)=NOC2=C1 VOMKSBFLAZZBOW-UHFFFAOYSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960000635 paliperidone palmitate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/21—General characteristics of the apparatus insensitive to tilting or inclination, e.g. spill-over prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/06—Packaging for specific medical equipment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119305P | 2020-11-30 | 2020-11-30 | |
| US202163237883P | 2021-08-27 | 2021-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4005555T3 true DK4005555T3 (da) | 2024-05-27 |
Family
ID=78789763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21210307.1T DK4005555T3 (da) | 2020-11-30 | 2021-11-24 | Fremgangsmåder til at sikre resuspension af paliperidonpalmitat-formuleringer |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11666697B2 (da) |
| EP (1) | EP4005555B1 (da) |
| JP (1) | JP2023551007A (da) |
| KR (1) | KR20230116008A (da) |
| AU (1) | AU2021388842A1 (da) |
| CA (1) | CA3203567A1 (da) |
| DK (1) | DK4005555T3 (da) |
| FI (1) | FI4005555T3 (da) |
| IL (1) | IL303254A (da) |
| LT (1) | LT4005555T (da) |
| MX (1) | MX2023006369A (da) |
| PT (1) | PT4005555T (da) |
| RS (1) | RS65612B1 (da) |
| WO (1) | WO2022112367A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3203015A1 (en) | 2020-11-30 | 2022-06-02 | Janssen Pharmaceutica Nv | Dosing regimens associated with extended release paliperidone injectable formulations |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254556A (en) | 1988-11-07 | 1993-10-19 | Janssen Pharmaceutica N.V. | 3-piperidinyl-1,2-benzisoxazoles |
| TW487572B (en) | 1996-05-20 | 2002-05-21 | Janssen Pharmaceutica Nv | Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
| LT2234617T (lt) | 2007-12-19 | 2021-05-25 | Janssen Pharmaceutica Nv | Dozės režimai, susiję su ilgo veikimo injekuojamais paliperidono esteriais |
| PL3280416T3 (pl) | 2015-04-07 | 2020-12-14 | Janssen Pharmaceuticals, Inc. | Reżim dawkowania dla pominiętych dawek dla długo działających wstrzykiwalnych estrów paliperydonu |
| WO2016199170A2 (en) * | 2015-06-10 | 2016-12-15 | Cipla Limited | Paliperidone palmitate particles and compositions thereof |
| JP6668387B2 (ja) * | 2015-06-19 | 2020-03-18 | ヤンセン ファーマシューティカ エヌ．ベー． | 薬物の投与及び混合のための装置及び方法、並びにそのための適切な技法のトレーニング |
| US20220062557A1 (en) | 2020-09-02 | 2022-03-03 | Janssen Pharmaceutica Nv | Pre-filled syringe with optimized stopper placement |
| CA3203448A1 (en) | 2020-11-30 | 2022-06-02 | Janssen Pharmaceutica Nv | Dosing regimens associated with extended release paliperidone injectable formulations |
| CA3203015A1 (en) | 2020-11-30 | 2022-06-02 | Janssen Pharmaceutica Nv | Dosing regimens associated with extended release paliperidone injectable formulations |
| EP4356966A3 (en) | 2020-11-30 | 2024-07-17 | JANSSEN Pharmaceutica NV | Dosing regimens associated with extended release paliperidone injectable formulations |
-
2021
- 2021-11-24 MX MX2023006369A patent/MX2023006369A/es unknown
- 2021-11-24 IL IL303254A patent/IL303254A/en unknown
- 2021-11-24 DK DK21210307.1T patent/DK4005555T3/da active
- 2021-11-24 JP JP2023532442A patent/JP2023551007A/ja active Pending
- 2021-11-24 RS RS20240602A patent/RS65612B1/sr unknown
- 2021-11-24 EP EP21210307.1A patent/EP4005555B1/en active Active
- 2021-11-24 US US17/534,837 patent/US11666697B2/en active Active
- 2021-11-24 AU AU2021388842A patent/AU2021388842A1/en active Pending
- 2021-11-24 PT PT212103071T patent/PT4005555T/pt unknown
- 2021-11-24 FI FIEP21210307.1T patent/FI4005555T3/fi active
- 2021-11-24 CA CA3203567A patent/CA3203567A1/en active Pending
- 2021-11-24 WO PCT/EP2021/082891 patent/WO2022112367A1/en active Application Filing
- 2021-11-24 LT LTEP21210307.1T patent/LT4005555T/lt unknown
- 2021-11-24 KR KR1020237020858A patent/KR20230116008A/ko unknown
-
2023
- 2023-04-11 US US18/298,580 patent/US20230241304A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| LT4005555T (lt) | 2024-06-25 |
| IL303254A (en) | 2023-07-01 |
| US20230241304A1 (en) | 2023-08-03 |
| CA3203567A1 (en) | 2022-06-02 |
| KR20230116008A (ko) | 2023-08-03 |
| AU2021388842A1 (en) | 2023-07-13 |
| MX2023006369A (es) | 2023-08-09 |
| PT4005555T (pt) | 2024-05-23 |
| US11666697B2 (en) | 2023-06-06 |
| FI4005555T3 (fi) | 2024-06-18 |
| US20220168497A1 (en) | 2022-06-02 |
| RS65612B1 (sr) | 2024-07-31 |
| EP4005555A1 (en) | 2022-06-01 |
| WO2022112367A1 (en) | 2022-06-02 |
| EP4005555B1 (en) | 2024-05-15 |
| JP2023551007A (ja) | 2023-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR23C1026I2 (fr) | Fabrication de formulations d'arachides pour désensibilisation orale | |
| DK3510033T3 (da) | Forbindelser og sammensætninger som inhibitorer af endosomale toll-lignende receptorer | |
| DK3350157T3 (da) | Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler | |
| DK3596041T3 (da) | Forbindelse og sammensætninger til intracellulær afgivelse af terapeutiske midler | |
| DK3443096T3 (da) | Sammensætninger og fremgangsmåder til selektiv ekspression af kimære antigenreceptorer | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| HK1247822A1 (zh) | 用於活性劑口服給藥的製劑 | |
| IL260263A (en) | Safety controls for a network connected autonomous vehicle | |
| DK2817000T3 (da) | Orale farmaceutiske sammensætninger af dabigatranetexilat | |
| MA44238A (fr) | Procédés d'augmentation de l'efficacité d'un vaccin par administration d'un antagoniste d'il-4r | |
| DK2680832T3 (da) | Vandig farmaceutisk formulering af tapentadol til oral administration | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK3317394T3 (da) | Anordning til opformering af mikrovæv | |
| PE20151997A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| DK3269716T3 (da) | Hidtil ukendte forbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske lidelser | |
| DK3192500T3 (da) | Sammensætninger til kontinuerlig indgivelse af dopa-decarboxylasehæmmere | |
| DK3325080T3 (da) | Fremgangsmåder til bedre indgivelse af aktive midler til tumorer | |
| DK3512857T3 (da) | Spiro-bicykliske inhibitorer af menin-mll-interaktion | |
| DK3294911T3 (da) | Platform til opdagelse og analyse af terapeutiske midler | |
| DK3943070T3 (da) | Langtidsvirkende formuleringer af bedaquilin | |
| IL275639A (en) | Formulation for RNA administration | |
| IL259952A (en) | Use of tryptophan derivatives for protein formulations | |
| DK2931313T3 (da) | Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer | |
| IL264880A (en) | Preparations for oral administration of active substances | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme |